| Siffror i utdrag Antalet projekt i fas I-III har minskat med 14 procent sedan 2010. 2011 fanns 63 projekt i nämnda faser, 2010 fanns 73. 35 företag har under 2011 projekt i fas I-III. |
- Skulle denna projektportfölj finnas i ett enda företag vore det ingen oäven utveckling, säger Hans Sivertsson, tf vd för Sweden Bio.
Totalt sett har antalet projekt i klinisk fas minskat med 14 procent sedan 2010. I år rapporterade de 75 företagen som svarade på undersökningen att de hade 63 projekt i klinisk fas medan bolagen som svarade 2010 hade 73 projekt i klinik.
Cancer är det terapiområde inom vilket bolagen har flest projekt. Sedan 2008 har bolagen haft mellan 12-14 projekt i fas III inom cancer.
Akademin spelar fortfarande en viktig roll för svenska bioteknik-företag, men rapporten visar en ökning i antalet projekt som utvecklats innanför bolagets väggar. Under 2011 är nära hälften av pipeline-projekten utvecklade internt på bolagen.
Sweden Bio, Vinnova och Invest Sweden har sedan 2005 årligen gjort en genomgång av den svenska life science-industrins produktportföljer. I årets rapport har 75 deltagit i undersökningen
De bolag som är med i undersökningen utför alla forskning i Sverige.
Astrazeneca räknas inte med då de inte anger från vilket land projektet härstammar.










































"Discover your possibilities in one of Europe´s most productive life science regions. Welcome to Stockholm-Uppsala."
"
"Our aim is to be the best drug development partner to the biotechnology and pharmaceutical industry no matter where you are based."
"Our services in ligand-based and structure-based drug design is a cost-efficient alternative for smaller pharmaceutical companies"
"To supply Swedish and Danish laboratories with laboratory equipment and furniture of highest quality and offer service on all delivered products."
"We aim to be the pioneering benchmark in user-friendly software experience in combination with the highest level of quality."
"We promise to go the extra mile every day to ensure you receive the highest level of service and value with each shipment you entrust to us."
"TFS is today the leading European development partner for biopharmaceutical companies in their global clinical development process."
"Allenex is a life science company that develops, manufactures, markets and sells high quality products for the transplantation market."
"We turn medical research into applications for better health and well-being."
"Your work is important to us, we are committed to your success.
Innovative tools? Please download the Promega app."
"With our first class products and our committed and skilled colleagues we guarantee our customers the best support in the market, at no extra charge."
"To develop innovative and effective pharmaceuticals within autoimmune/ inflammatory diseases and cancer where major medical need exists"
"To be the most attractive node and business platform in the Nordic countries for new and innovative Life Science companies"
"Best in class companies see the value of optimising their business by having an effective strategy for information management and documentation."
"Our products enable an increased number of transplants leading to substantial cost savings for society and increased quality of life for patients."
"We have a unique technological platform, built around 5HT-receptor antagonism, for the treatment of inflammation and pain"."
"Our vision is to become one of the top 10 global providers of scientific instruments; we will get there by striving for market leadership in our respective product and application niches."
"
"Our reliability, customer service, global network and integrated technology make World Courier service truly "A service no one else can deliver"."
"PCG - a professional full service CRO for your clinical trials.
Powered by Viedoc, globally trusted eCRF, keeping trials within budget and timelines"
"Mercodia has been a supplier of reliable assays since 1991"
"Anton Paar is a product and service leader in the field of scientific instruments. We deliver uncompromised quality in everything we do."
"Novel products for CVD treatment and prevention."
"As a full service CRO with offices in all Nordic countries we can provide our customer with professional support throughout the clinical research."
"Dilafor is developing new products in the field of obstetrics, to provide an effective solution to the challenge of dystocia or protracted labor"
"
"APL provides high-quality services to Life Science. We are a Dedicated Partner from Discovery to Market."
"The PolyPeptide Group is a world class manufacturer of peptide active pharmaceutical ingredients."
"VWR is a global laboratory distributor of chemicals, life science products, consumables, equipment, instruments, furniture, e-commerce and services"
"Our goal is to invest in innovations and develop new unique pharmaceuticals"
"We are making it more attractive for companies to invest in innovation with reduced corporation tax on profits from patents to 10%."
"We are entirely devoted to luminescence technology."
"Your global partner of pharmaceutical service and cGMP manufacturing"
"Medivir is a specialty pharmaceutical company with unique positioning on the Nordic market and our goal is become a profitable company in high growth"
"We offer effective staffing solutions provided by specialists, we understand a company’s specific needs and we know where to find the best talent."
"We help our clients create significant business value through scientific expertise."
"Our organisation value is to contribute to positioning Scandinavian healthcare and research in absolute world class."
"We are recognized as a flexible partner with short decision and lead times plus a proven record for the highest quality and cost efficiency."
"To adapt Competent Authorities´ requirements into opportunities is not just an artform - today it´s a business necessity."
"Innovation takes place when biology meets engineering; ICT is an enabler to solve the needs for increased functionality and reduced cost in Life Science"
"Uppsala BIO is a life science pathfinder. We build ways to make life science flourish, in cooperation with industry, academia, society and healthcare." 
